Pharma Excipients
Proteins
The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary…
Abstract
Lipid nanoparticles (LNPs) are of significant interest as delivery systems for various RNA therapeutics, not least due to their outstanding success in applications including the COVID-19 vaccines and the siRNA therapeutic Onpattro®. As LNPs consist of different lipids, the lipid…
Read More...
Read More...
Pickering emulsion gels stabilized by protein and polysaccharide-based particles: A review of…
Abstract
With a far longer stability than traditional emulsions, Pickering emulsion gels (PKEGs)—stabilized by solid particles—have proven highly efficient in a range of applications during recent years. Particles based on proteins or polysaccharides with distinctive amphiphilic structure are…
Read More...
Read More...
Storage and in-use stability of an excipient enhanced growth (EEG) synthetic lung surfactant powder…
Abstract
Objective
To evaluate the storage and in-use stability of a novel synthetic lung surfactant (SLS) excipient enhanced growth (EEG) powder formulation.
Significance
Aerosol delivery of surfactant formulations could address limitations of current instilled surfactant replacement therapy…
Read More...
Read More...
Nano-Engineered Epigallocatechin Gallate (EGCG) Delivery Systems: Overcoming Bioavailability…
Abstract
Epigallocatechin gallate (EGCG), a bioactive polyphenol derived from Camellia sinensis, exhibits multimodal anticancer activity through mechanisms such as apoptosis induction, metastasis suppression, and chemoresistance reversal. Despite its therapeutic promise, clinical application is…
Read More...
Read More...
Hydrogels in Drug Delivery – Part 2
Hydrogels in Drug Delivery
See the new book, edited by Alejandro J. Paredes, Garry Laverty, Eneko Larrañeta, Ryan F. Donnelly. It covers the fundamental mechanisms of drug delivery from a hydrophilic matrix, breaks down interconnections between introductory theory and applied materials chapters and…
Read More...
Read More...
Hydrogels in Drug Delivery – Part 1
Hydrogels in Drug Delivery
See the new book, edited by Alejandro J. Paredes, Garry Laverty, Eneko Larrañeta, Ryan F. Donnelly. It covers the fundamental mechanisms of drug delivery from a hydrophilic matrix, breaks down interconnections between introductory theory and applied materials chapters and…
Read More...
Read More...
Advances in the Oral Delivery of Protein and Peptide Drugs
Abstract
Protein and peptide drugs (PPDs) are highly effective therapies for a wide range of diseases, including cancer, diabetes, and autoimmune disorders . However, delivering these drugs orally presents significant challenges. PPDs face substantial barriers to attaining oral bioavailability,…
Read More...
Read More...
Assessing the impact of viscosity lowering excipient on liquid-liquid phase separation for high…
Abstract
With continued interest in high concentration monoclonal antibody drug products to meet subcutaneous administration requirements, there is heightened attention on balancing protein-protein interactions, solution properties and overcoming instabilities such as increased in viscosity,…
Read More...
Read More...
Excipient effect on phenol-induced precipitation of human growth hormone and bovine serum albumin
Abstract
The aim of this study was to investigate the impact of phenol on the precipitation of bovine serum albumin (BSA) and human growth hormone (hGH), in the presence of other excipients frequently used in biological drugs for parenteral delivery. The focus of the study lieson incompatibilities…
Read More...
Read More...
Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical…
Peptide and protein (PP) therapeutics are highly specific and potent biomolecules that treat chronic and complex diseases. However, their oral delivery is significantly hindered by enzymatic degradation, instability, and poor permeability through the gastrointestinal (GI) epithelium, resulting in…
Read More...
Read More...